Archives for July 4, 2023

Complex road ahead, despite phase 3 progress, for Annovis’ buntanetap in Parkinson’s Disease

Drugs like Annovis Bio’s buntanetap and prasinezumab have the potential to “revolutionize the treatment of Parkinson’s Disease” says analytics company, GlobalData, an analytics company, but it is a complex road ahead.

Clerkenwell Health to sponsor Psych Symposium London as it urges NHS to ‘embrace’ psychedelics

Clerkenwell Health, a specialist clinical research organisation (CRO) focused on supporting clients with the design and delivery of psychedelic-assisted therapy trials, is sponsoring the upcoming Psych Symposium 2023 on Thursday 6 July in London.

DIA Global

Curavit: Tackling underrepresentation with the right balance of patient care, science and business

New guidelines have been issued by the FDA called Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials. Curavit was ahead of the game with its plans, find out how.